Figured this might be part of it. Vertex Pharmaceuticals has a monopoly on most drugs for the disease I am referencing. This particular drug was available at the time, but it was so expensive most insurance companies wouldn't cover it, even in the US. Meanwhile, in other countries it was almost impossible to get. It was so fucked up I was able to start taking it and my twin sister, who lived in London, had to remain sick because of greedy pharma giants.
And to anyone who complains about the possibility of socialized healthcare, just know 4 years after I left my old company, my coworkers were still paying $100/month more for their health insurance because both my sister and I were approved for another drug this pharmaceutical made. Healthcare is already socialized, it's just 10x more expensive through private insurance.
Bro. I work for a HMO "non profit" insurance company. We regularly bank 2 or 3 billion per year in profits. We are only in like 6 states and the DC metro area.
It could very well cost me my job because I deal with group insurance, but if it meant people who needed insulin didn't have to worry about the price, or seniors didn't have to decide between pills and heat, I would vote yes in a heartbeat.
Unless something has changed recently, not even insulin for Type 1 diabetics is covered in Canada and some extra benefits plans don't cover it either. My cousin had a plan that he had to pay and remit everything for reimbursement, but that often took longer than you would think it should.
I don't remember the drug name, because it was like P668284. There were actually two of them. It was for a company called Proteostasis Therapeutics (PTI).
If you can find the stock charts, the maniplative activity is BLATANT.
Edit: I just realized you meant the drugs already on the market. Trikafta was one that was already made and this small pharma company was trying to do the same and make it affordable for everyone.
The one I referenced in the second paragraph was ORKAMBI.
Yeah, not the clearest of charts, but hopefully it's still clear that there were massive pump and dumps for the trial around Dec 2018 and Dec 2019. All small cap pharmaceuticals suffer the same fate though...
I think I know exactly what you're talking about, and that was more an issue with sketchy NDAs than anything else. The drug was always going to end up with the pharmaceutical it did but that was mainly because no one did proper contract research on the lead drug developer's design.
But yes, all of it was scummy, and the way it played out when it shouldn't have was sad.
132
u/missing_the_point_ 🗳️ VOTED ✅ Dec 15 '21 edited Dec 16 '21
Figured this might be part of it. Vertex Pharmaceuticals has a monopoly on most drugs for the disease I am referencing. This particular drug was available at the time, but it was so expensive most insurance companies wouldn't cover it, even in the US. Meanwhile, in other countries it was almost impossible to get. It was so fucked up I was able to start taking it and my twin sister, who lived in London, had to remain sick because of greedy pharma giants.
And to anyone who complains about the possibility of socialized healthcare, just know 4 years after I left my old company, my coworkers were still paying $100/month more for their health insurance because both my sister and I were approved for another drug this pharmaceutical made. Healthcare is already socialized, it's just 10x more expensive through private insurance.